{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:16Z","timestamp":1786118896895,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1097\/jcp.0b013e31814f4d5d","type":"journal-article","created":{"date-parts":[[2007,9,12]],"date-time":"2007-09-12T03:02:59Z","timestamp":1189566179000},"page":"524-525","source":"Crossref","is-referenced-by-count":10,"title":["Resolution of Haloperidol-Induced Hyperprolactinemia With Aripiprazole"],"prefix":"10.1097","volume":"27","author":[{"given":"Raymond A.","family":"Lorenz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-25-20210128","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0169-328X(98)00009-6","article-title":"Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary.","volume":"55","author":"Inoue","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"R2-25-20210128","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1517\/14656566.3.10.1381","article-title":"Antipsychotics: impact on prolactin levels.","volume":"3","author":"Goodnick","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"R3-25-20210128","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1176\/appi.ajp.162.8.1542-a","article-title":"Reversal of symptomatic hyperprolactinemia by aripiprazole.","volume":"162","author":"Wahl","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R4-25-20210128","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.pnpbp.2006.02.001","article-title":"Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study.","volume":"30","author":"Lee","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R5-25-20210128","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.4088\/JCP.v65n0918f","article-title":"Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: a case report.","volume":"65","author":"Anghelescu","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R6-25-20210128","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1159\/000087790","article-title":"Galactorrhea with aripiprazole.","volume":"74","author":"Ruffatti","year":"2005","journal-title":"Psychother Psychosom"},{"key":"R7-25-20210128","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1177\/070674370505000413","article-title":"Galactorrhea with aripiprazole.","volume":"50","author":"Mendhekar","year":"2005","journal-title":"Can J Psychiatry"},{"key":"R8-25-20210128","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features, and management.","volume":"64","author":"Haddad","year":"2004","journal-title":"Drugs"},{"key":"R9-25-20210128","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/archpsyc.60.10.974","article-title":"Mechanism of new antipsychotic medications: occupancy is not just antagonism.","volume":"60","author":"Grunder","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R10-25-20210128","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2003.09.082","article-title":"The novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin release.","volume":"1003","author":"Aihara","year":"2004","journal-title":"Brain Res"},{"key":"R11-25-20210128","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.npp.1300412","article-title":"From galactorrhea to osteopenia: rethinking serotonin-prolactin interactions.","volume":"29","author":"Emiliano","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"R12-25-20210128","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology.","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-200710000-00025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:59:20Z","timestamp":1786035560000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-200710000-00025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31814f4d5d","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}